Three different tetraazamacrocyclic ligands containing four amide substituents that feature groups (namely allyl, styryl and propargyl groups) suitable for polymerisation have been synthesised. Gadolinium(III) complexes of these three ligands have been prepared as potential monomers for the synthesis of polymeric MRI contrast agents. To assess the potential of these monomers as MRI contrast agents, their relaxation enhancement properties and cytotoxicity have been determined. A europium(III) complex of one of these ligands (with propargyl substituents) is also presented together with its PARACEST properties. In addition, to gain further insight into the coordination chemistry of the tetra-propargyl substitited ligand, the corresponding zinc(II) and cadmium(II) complexes have been prepared.
Introduction
Polyazamacrocycles substituted with coordinating pendant arms have shown to be excellent ligands for a wide range of metal ions. 1, 2 The resulting complexes are generally thermodynamically very stable, which has resulted in these systems being used in a range of different applications. 3 For example, coordination of this type of ligand to metals such as 90 Y, 68 Ga and 111 In yields complexes that have been successfully used as radiopharmaceuticals for imaging and therapy. [4] [5] [6] [7] [8] [9] [10] On the other hand, complexes of substituted polyazamacrocycles with lanthanides (e.g. Eu III , Tb III and Gd III ) have been shown to be excellent molecular probes for optical [11] [12] [13] [14] [15] and magnetic resonance imaging (MRI). [16] [17] [18] [19] There are currently five gadolinium(III) complexes approved by the FDA for use as MRI contrast agents in the US. From these, two (Dotarem® and Prohance®) are based on tetraazamacrocyclic derivatives (see Scheme 1) . In spite of the great impact these complexes have had in the medical applications of MRI, their performance at clinically relevant concentrations is limited and well below what can be achieved theoretically. 20 Consequently, there has been interest in finding new types of complexes that optimise the various factors which affect the ability of gadolinium(III) to change the relaxation time of water molecules. 21 Several approaches have been investigated such as increasing the number of water molecules coordinating to gadolinium (q); optimising the water exchange rate (1/τ m ); increasing the rotational correlation time (τ R ) of the contrast agent. The later is a promising approach and has been successfully employed by attaching gadolinium complexes to high molecular weight platforms such as cyclodextrins, 22 ,23 dendrimers [24] [25] [26] [27] [28] and less well defined polymers. 21, 29, 30 Besides their potential beneficial effect in slowing tumbling, high molecular weight materials also have the advantage of increasing the load of gadolinium per molecule with the consequent increase in relaxivity. 31 Another interesting approach that has been gaining terrain recently is the development of lanthanide-based MRI contrast agents that operate via the chemical exchange saturation transfer (CEST) mechanism. [32] [33] [34] These PARACEST agents are often based on Ln-DOTA-tetramide complexes (e.g. with Eu and Yb); this type of complex displays very slow water exchange kinetics which is ideal for the CEST phenomenon to take place. Also in this approach, there is interest in developing polymeric materials containing a large number of lanthanide centres to provide highly sensitive molecular probes. 35 For the reasons outlined above, we are interested in developing novel MRI contrast agents based on hyperbranched polymers. Therefore, we have synthesised a series of tetraazamacrocyclic ligands containing four amide substituents that feature functional groups suitable for free-radical, ADMET, cross-coupling and cycloaddition (e.g. 1,3-dipolar cycloadditions, "click") polymerisation approaches (see Scheme 2).
Scheme 1 -Two examples, Dotarem® and Prohance®, of clinically approved MRI contrast agents that make use of the azamacrocyclic ligands DOTA and HPDO3A shown in this scheme.
Herein we present the synthesis and characterisation of three of such tetraazamacrocyclic ligands and their corresponding gadolinium(III) complexes (and in one case also a europium(III) complex). To assess their potential as MRI contrast agents (as part of a larger polymeric structure), their relaxation enhancement properties have been investigated as well as their cytotoxicity at concentrations relevant for MRI. As per the europium(III) complex herein presented, its potential as PARACEST agent has been evaluated. In addition, to gain insight into the structural features of the ligands and complexes, X-ray crystallographic studies have been carried out of one of the ligands (the tetra-propargyl derivative) and its corresponding gadolinium(III), cadmium(II) and zinc(II) complexes.
Results and Discussion

Synthesis
The tetra-substituted tetraazamacrocyclic ligands 4-6 (see Scheme 2) were prepared by reacting cyclen with the corresponding chloro-acetamides (1-3). Compounds 4 and 6 have not been reported before while the synthesis of 5 (via a different route) was published by Antoni in the course of this investigation. 36 The three products were isolated as white or off-white solids in 58 to 74% yields and were fully characterised by spectroscopic and analytical techniques, and in one case (compound 5) by X-ray crystallography (vide infra). Scheme 2 -Reaction scheme showing the syntheses of all ligands and metal complexes used in this study.
The europium complex 9 (see Scheme 2) was prepared using a similar synthetic methodology than that used for to the gadolinium(III) complex 8 described above. Mass spectrometry, 1 H NMR spectroscopy and elemental analyses were all consistent with the formation of the correct complex. 37 Interestingly, in the region above 5 ppm (where the resonance for the axial ethylene unit appears) only one resonance at 24 ppm was observed.
This resonance and the absence of any other between 5 and 12 ppm suggest that in solution complex 9 is present in a mono-capped square antiprismatic geometry and not as a mixture of isomers (the second being the mono-capped twisted square antiprismatic geometry ) as is often the case with DOTA-tetramide lanthanide complexes. 37 In addition, the emission spectrum of this complex was recorded showing the expected transitions for cyclen-based europium(III) complexes 38 (see Figure 1 ). In order to gain more insight into the coordinating abilities of these ligands, one of them (ligand 5) was also reacted with zinc(II) and cadmium(II) perchlorates. It has been previously shown that these metal ions (in particular cadmium(II)) often coordinate to cyclen derivatives in a similar fashion than gadolinium(III) does. 39 An advantage of using cadmium(II) and zinc(II) is that, having a closed shell (d 10 ), they are diamagnetic and therefore the resulting complexes can be studied by NMR spectroscopy. Thus, reaction of the tetra-propargyl ligand Tables 1, 2 and 3 . It can readily be seen that whilst in the free ligand the four amide arms are spread out (Figure 2 ), in the presence of a metal ion coordinated to all four of the cyclen nitrogen centres, some or all of the arms wrap around and encapsulate the metal centre.
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Figure 2
The structure of the C i -symmetric molecule 5.
In the gadolinium and cadmium complexes 8 and 11, the tetra-propargyl cyclen ligand adopts an octadentate coordination mode with the carbonyl oxygen atoms of all four amide arms binding to the metal (see Figure 3 and 4). 168 and 43° respectively.
Fig. 5
The molecular structure of the C 2 -symmetric cationic complex present in the crystals of 12, viewed along the crystallographic C 2 axis direction.
Fig. 6
The coordination sphere around the zinc atom in the structure of 12 showing the distorted octahedral coordination geometry. Table 1 . Selected bond lengths (Å) and angles (°) for 8. Table 4 . Comparative X-N-C-C torsion angles (°) for each amide arm of the tetrapropargyl cyclen ligand in the structures of 5, 8, 11 and 12.
[a]
n/a -37 n/a n/a X-N(10)-C-C n/a -38 n/a n/a [a] X is either the nitrogen lone pair or the coordinated metal atom. 
n/a 30 n/a n/a N(10)-C-C-O (32) n/a 31 n/a n/a Determination of relaxivity of gadolinium complexes 7 and 8. Once the gadolinium complexes 7, 8 and 10 were prepared and fully characterised, it was of interest to determine their potential as MRI contrast agents. Therefore relaxivity determinations were carried out using two of the complexes (7 and 8). Complex 10 showed to have limited solubility in water and therefore was excluded of any further relaxivity and cell viability (see next section) studies. Relaxation rates were measured at 25°C using 2.35 T (100 MHz) and 9.4 T (400 MHz) systems. Solutions of the corresponding complexes at 0.1-2.5 mM concentration range in double distilled water were prepared and the relaxivities determined (see Table 6 ). were also determined by using a spin-echo technique. This parameter is rarely reported for Gd-based contrast agents and indeed no transversal relaxivity values were found in the literature for any Gd-DOTA-tetraamide complexes making any comparison difficult. As a reference, the previously reported r 2 value (at B = 2.35 T) for Gd-DOTA is 4.9 mM -1 s -1 .
43
CEST spectrum of PARACEST agent 9. The PARACEST spectrum of the europium complex 9 was recorded (see Figure 7 ) by applying selective saturation between +100 and - was investigated by incubating ST14A stem cells 45 (an immortalized neural stem cell line derived from embryonic striatum at developmental stage E14) in solutions containing different concentrations of the corresponding complex, at 33°C and 5% CO 2 atmosphere for 24 hours. Solutions of 7 and 8 ranging from 0.01 to 10 mM were prepared in DMEM.
Incubation was then carried out with these solutions, after which the cells were washed with EBSS and tested for viability. Cells were first checked under an inverted microscope to assess morphological changes as possible occurrence of cell death. 
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For a quantitative analysis of the effect of compounds 7 and 8 on cell survival, change in cell metabolism was assessed using the Alamar Blue ( Figure 9 and Table 7 ) 46 and
Methylene Blue 47 assays ( Figure 10 and Table 7 ). These methods utilize dyes that detect either changes in the redox state of the culture medium resulting from cell growth (Alamar Blue assay), or that bind to living cell membranes (Methylene Blue assay). Across the range of concentrations, both complexes showed similar metabolic activity and cytotoxicity as the control cells which were not exposed to gadolinium complexes. In the Alamar Blue assay, a small, though statistically different, reduction in cell number appeared to be induced by treatment with compound 8 at 0.1 mM and 0.01 mM (Figure 7 ; p=0.015). In the Methylene
Blue assay, a concentration-dependent effect on cell viability was observed, and cell number at 3 mM using compound 8 was statistically lower than in control cells (Figure 8 ; p=0.001).
Microscopy indicated that cells at the range of concentrations tested in the viability assays (0.01-3 mM) were not visibly undergoing cell death, suggesting that the results of the Alamar
Blue and Methylene Blue assays may reflect an effect of the compounds on cell metabolism and proliferation, respectively, rather than in cell survival. Whereas the Methylene Blue assay provides a measure of the dye bound to living cell membranes, and its binding is an indicator of the number of cells in culture, 47 the Alamar Blue assay detects dye colour changes due to oxidation-reduction activity, providing a measure of cell metabolic activity. Altogether our results suggest that compound 7 is non-toxic at and below 3 mM, while at 3 mM cell numbers decrease for compound 8. However, as indicated above, our aim is to polymerise these monomeric units to generate materials that would provide a higher payload of gadolinium per molecule increasing the relaxivity this way. This polymeric materials could also see a further enhancement of the relaxivity due to the slower tumbling of the resulting molecules, although this effect is minimised in systems were the water exchange is slow as is likely to be the case here (in spite of this, second coordination sphere interactions can overcome this problem -see for example the recent publication by Sherry 48 ). The cytotoxicity studies indicate that one of the compounds under study (7) is non-toxic at and below 3 mM, while a slight cytotoxicity was observed for compound 8 at 3 mM (but not at lower concentrations). We also studied the PARACEST properties of europium(III) complex 9 which showed to have an intermediate to slow water exchange between the Eu-bound water species and bulk water, as expected. In addition to these studies -directed towards the development of novel MRI contrast agentswe also carried out a detailed structural study of one of the ligands (with propargyl substituents) and the corresponding Gd III , Cd II and Zn II complexes. The single crystal X-ray crystallographic studies showed the ligand to be octadentate for the gadolinium and cadmium complexes and hexadentate in the case of zinc. This is consistent with the coordination chemistry expected in each case.
We are currently investigating the formation of hyperbranched polymers from these monomers; the resulting species will in turn be loaded with gadolinium(III) to yield new MRI contrast agents. These results will be reported in due course. Elemental analyses were performed by the Elemental Analysis Service at London Metropolitan University. All 1 H NMR spectra were recorded as solutions in specified deuterated solvents on a Bruker 2 channel DRX-400 spectrometer using the residual protic solvent signal as internal reference. 13 C NMR spectra were recorded on a Bruker 2 channel DRX-400 spectrometer as solutions in specified deuterated solvents. FT-IR spectra were recorded on a Perkin-Elmer Spectrum RX FT-IR spectrometer with built-in internal calibration. The compound to analyse was either pressed together with fine anhydrous potassium bromide to obtain a disk, or added as a thin layer between KBr pellets. Mass spectra were recorded under CI + or FAB + conditions on a Micromass AutoSpec Premier instrument, or ESI + conditions using a Micromass LCT Premier instrument. Fluorescence emission spectra were obtained using a Horiba Jobin Yvon, Fluorolog-3 spectrofluorimeter, using 10 x 10 mm quartz cuvettes.
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N-allyl-2-chloroacetamide, 1. Chloroacetyl chloride (0.80 ml, 10 mmol) in dry THF (2 ml) was cooled down to -10 °C on an ice bath. A solution of dry allylamine (0.75 ml, 10 mmol) and dry Et 3 N (1.39 ml, 10.0 mmol) in dry THF (2 ml) was added dropwise over 1 hour at -10 °C. The mixture was left stirring for 1 h. After removal of the solvent under reduced pressure, 0.1 M HCl (15 ml) was added, and the product was extracted with CHCl 3 .
The organic phase was dried over anhydrous K 2 CO 3 . 
(CO).
1,4,7,10-tetrakis((prop-2-ynyl)carbamoylmethyl)-1,4,7,10-tetraazacyclododecane (5).
In the course of this investigation, the synthesis of this compound was reported. Our synthetic methodology differs slightly from the reported and is therefore reported herein. CEST NMR experiment. CEST measurements were carried out by following a previously reported procedure. 49 The sample for CEST study was prepared by dissolving the appropriate amount of complex 9 in H 2 O:D 2 O 9:1 to yield a 20 mM solution. NMR spectra were recorded on a Bruker Avance NMR spectrometer equipped with a narrow-bore 9.4 T superconducting magnet. 
